Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
UMC Utrecht ZonMw: The Netherlands Organisation for Health Research and Development |
---|---|
Information provided by: | UMC Utrecht |
ClinicalTrials.gov Identifier: | NCT00232466 |
Percutaneous vertebroplasty is a new procedure for treating painful osteoporotic compression fractures of the spine. Five-thousand out of 12.000 patients (16.000 vertebral fractures/year in the Netherlands) present with sudden, severe back pain in the region of the fracture.Until recently, bed rest, analgesia and physical support were the only treatment options. After decades of performing PV, no large RCT with mid-term follow-up has been published.
Design:
This will be a multicenter (6 centers), prospective, randomised, intervention study. Eligible patients will be randomised for percutaneous vertebroplasty or conservative therapy.
Study population:
Age: 50 and older, vertebral fracture, level: thoracic vertebral body 5 (Th 5) or lower, osteopenia (T-score < -1 SD), back pain for no more than 6 weeks and edema in the vertebrae on MR imaging
Statistical analyses All analyses will be performed on an 'intention to treat' principle. The planned number of subjects will be 200 in total, 100 in each intervention arm.
Economic evaluation:
Cost-effectiveness will be assessed. The costs of the procedure and the medical treatment, and of visits to medical specialists, GP's and physical therapists will be compared.
Time schedule:
The total study will take 36 months
Recruitment of patients (200) has been completed. In May 2009 the 1 year follow-up will be finished.
Condition | Intervention |
---|---|
Osteoporosis Back Pain |
Procedure: Vertebroplasty |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | VERTOS II. Percutaneous Vertebroplasty Versus Conservative Therapy in Patients With Osteoporotic Vertebral Fractures |
Enrollment: | 200 |
Study Start Date: | October 2005 |
Estimated Study Completion Date: | May 2010 |
Estimated Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
2: No Intervention
conservative therapy (no intervention)
|
|
1: Active Comparator
Vertebroplasty
|
Procedure: Vertebroplasty
Procedure: The treatment consists of a transpedicular injection of polymethylmethacrylate bone cement into the collapsed vertebral body (maximal 2 vertebrae in 1 treatment session) using fluoroscopic guidance. The procedure is performed under the use of local anesthetics and the patient can be discharged the same day or after 1 night of hospital stay. |
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
Exclusion criteria:
Belgium | |
AZ St. Lucas Ziekenhuis | |
Gent, Belgium, 9000 | |
Netherlands | |
St. Elisabeth Ziekenhuis | |
Tilburg, Netherlands, 5022 GC | |
Catharina-Ziekenhuis | |
Eindhoven, Netherlands, 5623 EJ | |
Albert Schweizer Ziekenhuis | |
Dordrecht, Netherlands, 3300 AK | |
UMCU | |
Utrecht, Netherlands, 3508 GA | |
Netherlands, Utrecht | |
Diakonessenhuis | |
Utrecht/Zeist/Doorn, Utrecht, Netherlands, 3508 TG |
Principal Investigator: | Willem Mali, MD.PhD | UMC Utrecht |
Responsible Party: | UMC Utrecht ( Caroline Klazen ) |
Study ID Numbers: | 945-06-351, 945-06-351 |
Study First Received: | September 30, 2005 |
Last Updated: | June 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00232466 History of Changes |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Vertebroplasty Vertebral fracture Actonel |
Osteoporotic vertebral fractures |
Fractures, Bone Spinal Fractures Osteoporosis Anesthetics Pain Bone Diseases, Metabolic Back Pain |
Bone Diseases Anesthetics, Local Polymethyl Methacrylate Signs and Symptoms Musculoskeletal Diseases Neurologic Manifestations Risedronic acid |
Signs and Symptoms Musculoskeletal Diseases Nervous System Diseases Neurologic Manifestations Osteoporosis |
Bone Diseases, Metabolic Pain Bone Diseases Back Pain |